Nuttall James, Ma Julian K-C, Frigerio Lorenzo
Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK.
Plant Biotechnol J. 2005 Sep;3(5):497-504. doi: 10.1111/j.1467-7652.2005.00140.x.
A potential drawback in the use of plants as an expression platform for pharmaceutical proteins such as antibodies is that plant-specific N-glycosylation can result in proteins with altered function and potential antigenicity. In many cases, the N-glycans are essential for the correct folding, assembly and transport of the recombinant proteins. We tested whether progressive removal of glycosylation sites had a detrimental effect on the synthesis, assembly and secretion of a plant-made immunoglobulin G, Guy's 13. Our results indicate that the plant secretory pathway can cope well with aglycosylated antibody chains. The immunoglobulin without N-linked glycans is correctly assembled and secreted by tobacco protoplasts. Capture enzyme-linked immunosorbent assay also shows that antigen-binding properties are unaffected. Our results therefore suggest one possible alternative to the engineering of a humanized glycosylation machinery in plants.
将植物用作诸如抗体等药用蛋白质的表达平台时,一个潜在的缺点是植物特异性N-糖基化可能导致蛋白质功能改变并具有潜在的抗原性。在许多情况下,N-聚糖对于重组蛋白的正确折叠、组装和运输至关重要。我们测试了逐步去除糖基化位点是否会对植物制造的免疫球蛋白G(盖伊氏13)的合成、组装和分泌产生不利影响。我们的结果表明,植物分泌途径能够很好地应对无糖基化的抗体链。不含N-连接聚糖的免疫球蛋白由烟草原生质体正确组装并分泌。捕获酶联免疫吸附测定还表明,抗原结合特性未受影响。因此,我们的结果提示了一种可能替代在植物中构建人源化糖基化机制的方法。